UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 114

Sortiert nach

The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients’ Survival

BioMed research international, 2018-01, Vol.2018, p.2653623-9

2018

Link zum Volltext

Verfügbarkeit prüfen

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Journal of clinical oncology, 2019-06, Vol.37 (16), p.1412-1423

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound‐fusion biopsy for the diagnosis of prostate cancer

BJU international, 2015-12, Vol.116 (6), p.873-879

2015

Link zum Volltext

Verfügbarkeit prüfen

MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naïve Men

BioMed research international, 2015-01, Vol.2015, p.571708-6

2015

Link zum Volltext

Verfügbarkeit prüfen

Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma

PloS one, 2013-09, Vol.8 (9), p.e76386-e76386

2013

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Outcomes and Risk Factors for Patients with Renal Cell Carcinoma and Venous Tumor Thrombus after Radical Nephrectomy and Thrombectomy: The Prognostic Significance of Venous Tumor Thrombus Level

BioMed research international, 2015-01, Vol.2015, p.163423-8

2015

Link zum Volltext

Verfügbarkeit prüfen

Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma

PloS one, 2014-07, Vol.9 (7), p.e102262-e102262

2014

Link zum Volltext

Verfügbarkeit prüfen

Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy

BMC urology, 2018-10, Vol.18 (1), p.91-91, Article 91

2018

Link zum Volltext

Verfügbarkeit prüfen

Prostatakarzinom: ADT erhöht Risiko für rheumatoide Arthritis

Im Focus Onkologie, 2018-09, Vol.21 (9), p.80-82

2018

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis

BMC cancer, 2014-12, Vol.14 (1), p.974-974, Article 974

2014

Link zum Volltext

Verfügbarkeit prüfen

External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database

International journal of clinical oncology, 2020, Vol.25 (1), p.145-150

2020

Link zum Volltext

Verfügbarkeit prüfen

MP20-20 BETTER PREDICTION OF TUMOR AGGRESSIVENESS IN MRI/ULTRASOUND-FUSION-BIOPSY COMPARED TO SYSTEMATIC PROSTATE BIOPSY

The Journal of urology, 2018-04, Vol.199 (4), p.e261-e261

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of resection margin status after nephron‐sparing surgery for renal cell carcinoma

BJU international, 2006-06, Vol.97 (6), p.1208-1210

2006

Link zum Volltext

Verfügbarkeit prüfen

PD51-03 PREDICTING COMPETING MORTALITY IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY AT AN AGE OF 70 YEARS OR OLDER

The Journal of urology, 2017, Vol.197 (4), p.e985-e985

2017

Link zum Volltext

Verfügbarkeit prüfen

Systemic therapy in metastatic renal cell carcinoma

World Journal of Urology, 2017-02, Vol.35 (2), p.179-188

2017

Link zum Volltext

Verfügbarkeit prüfen

MP21-07 SELECTION EFFECTS MAY EXPLAIN SMOKING-RELATED OUTCOME DIFFERENCES AFTER RADICAL CYSTECTOMY

The Journal of urology, 2017-04, Vol.197 (4), p.e250-e250

2017

Link zum Volltext

Verfügbarkeit prüfen

Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography‐fusion biopsy

BJU international, 2016-08, Vol.118 (2), p.213-220

2016

Link zum Volltext

Verfügbarkeit prüfen

Management of testosterone in advanced hormone-sensitive prostate cancer: still up to date?

Aktuelle Urologie, 2022-02, Vol.53 (1), p.37

2022

Link zum Volltext

Verfügbarkeit prüfen

Advances in renal cell carcinoma treatment

Therapeutic Advances in Urology, 2010-02, Vol.2 (1), p.11-17

2010

Link zum Volltext

Verfügbarkeit prüfen

Predicting Competing Mortality in Patients Undergoing Radical Prostatectomy Aged 70 yr or Older

European urology, 2017-05, Vol.71 (5), p.710-713

2017

Link zum Volltext

Verfügbarkeit prüfen

MP57-12 PREDICTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN PATIENTS WITH PREVIOUSLY NEGATIVE PROSTATE BIOPSY UNDERGOING MRI/ULTRASOUND-FUSION BIOPSY IN COMBINATION WITH SYSTEMATIC BIOPSY

The Journal of urology, 2018-04, Vol.199 (4), p.e769-e769

2018

Link zum Volltext

Verfügbarkeit prüfen

MP12-04 ONLY LESS THAN 10% OF PATIENTS SELECTED FOR RADICAL PROSTATECTOMY REACH THE COMPETING MORTALITY RATE OF THE PROSTATE CANCER INTERVENTION VERSUS OBSERVATION TRIAL (PIVOT)

The Journal of urology, 2018-04, Vol.199 (4), p.e136-e136

2018

Link zum Volltext

Verfügbarkeit prüfen

Growth of a Level III Vena Cava Tumor Thrombus Within 1 Month

Urology (Ridgewood, N.J.), 2016-04, Vol.90, p.e1-e2

2016

Link zum Volltext

Verfügbarkeit prüfen

Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy‐naïve patients

BJU international, 2018-01, Vol.121 (1), p.53-60

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(107)
Japanisch
(7)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Immunoexpression of YAP1 and LATS1 Proteins in Clear Cell Renal Cell Carcinoma: Impact on Patients’ Survival

Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study

Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound‐fusion biopsy for the diagnosis of prostate cancer

MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naïve Men

A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy

Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma

Prognostic Outcomes and Risk Factors for Patients with Renal Cell Carcinoma and Venous Tumor Thrombus after Radical Nephrectomy and Thrombectomy: The Prognostic Significance of Venous Tumor Thrombus Level

Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma

Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy

Prostatakarzinom: ADT erhöht Risiko für rheumatoide Arthritis

Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis

External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database

MP20-20 BETTER PREDICTION OF TUMOR AGGRESSIVENESS IN MRI/ULTRASOUND-FUSION-BIOPSY COMPARED TO SYSTEMATIC PROSTATE BIOPSY

Impact of resection margin status after nephron‐sparing surgery for renal cell carcinoma

PD51-03 PREDICTING COMPETING MORTALITY IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY AT AN AGE OF 70 YEARS OR OLDER

Systemic therapy in metastatic renal cell carcinoma

MP21-07 SELECTION EFFECTS MAY EXPLAIN SMOKING-RELATED OUTCOME DIFFERENCES AFTER RADICAL CYSTECTOMY

Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography‐fusion biopsy

Management of testosterone in advanced hormone-sensitive prostate cancer: still up to date?

Advances in renal cell carcinoma treatment

Predicting Competing Mortality in Patients Undergoing Radical Prostatectomy Aged 70 yr or Older

MP57-12 PREDICTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER IN PATIENTS WITH PREVIOUSLY NEGATIVE PROSTATE BIOPSY UNDERGOING MRI/ULTRASOUND-FUSION BIOPSY IN COMBINATION WITH SYSTEMATIC BIOPSY

MP12-04 ONLY LESS THAN 10% OF PATIENTS SELECTED FOR RADICAL PROSTATECTOMY REACH THE COMPETING MORTALITY RATE OF THE PROSTATE CANCER INTERVENTION VERSUS OBSERVATION TRIAL (PIVOT)

Growth of a Level III Vena Cava Tumor Thrombus Within 1 Month

Prospective comparison of transperineal magnetic resonance imaging/ultrasonography fusion biopsy and transrectal systematic biopsy in biopsy‐naïve patients

Suchergebnisse filtern